Skip to main content

Table 1 Sequences of PCR primers

From: Uncovering the mechanism of resveratrol in the treatment of diabetic kidney disease based on network pharmacology, molecular docking, and experimental validation

Gene symbol

Accession number

Forward primer (5′–3′)

Reverse primer (5′–3′)

Expected amplicon size (base pair)

β-actin

NM_007393

TATGCTCTCCCTCACGCCATCC

GTCACGCACGATTTCCCTCTCAG

129

Nephrin

NM_019459

CTCCACGGTTAGCACAGCAGAAG

GCTTGGCGATATGACACCTCTTCC

102

WT1

NM_144783

CAGTGAAATGGACAGAAGGGCAGAG

ATACACGCCGCACATCCTGAATG

141

PPARA

NM_011144

CTTCACGATGCTGTCCTCCTTGATG

GATGTCACAGAACGGCTTCCTCAG

112

ESR1

NM_007956

CCTGGCTGGAGATTCTGATGATTGG

TCCACCATGCCTTCCACACATTTAC

124

SLC2A1

NM_011400

GATGAAAGAAGAGGGTCGGCAGATG

CAGCACCACAGCGATGAGGATG

106

SHBG

NM_011367

CTTCTGCTTCCTTCTGCCTGAGTG

CTAGTGGGAGGTGCGGGTATCG

140

AR

NM_013476

GGCAGCAGTGAAGCAGGTAGC

CAGAGCCAGCGGAAAGTTGTAGTAG

129

AKR1B1

NM_009658

AAGCCTGAAGATCCGTCTCTCCTG

CGCACTGGTGTCACAGACTTGG

143

PPARG

NM_011146

GCCAAGGTGCTCCAGAAGATGAC

GTGAAGGCTCATGTCTGTCTCTGTC

102

IGF1R

NM_010513

ATGCCAACAAGTTCGTCCACAGAG

TCCGTCTCGTAGATGTCTCGTGTC

112

RELA

NM_009045

CCAGACCAACAACAACCCCTTCC

AAGCAGAGCCGCACAGCATTC

81

PIK3CA

NM_008839

GCACAAGAGTACACCAAGACCAGAG

GCATTCCAGAGCCAAGCATCATTG

130

MMP9

NM_013599

CGCCACCACAGCCAACTATGAC

CTGCTTGCCCAGGAAGACGAAG

130

AKT1

NM_009652

TCAGGATGTGGATCAGCGAGAGTC

AGGCAGCGGATGATAAAGGTGTTG

108

INSR

NM_010568

ATCCGCCGCTCCTATGCTCTG

GAGTTGCCTCAGGTTCTGGTTGTC

126

MMP2

NM_008610

ACCATGCGGAAGCCAAGATGTG

AGGGTCCAGGTCAGGTGTGTAAC

126

TTR

NM_013697

ACACTTGGCATTTCCCCGTTCC

GCGATGGTGTAGTGGCGATGG

83